Overview

Effects of Heart Control at Different Stages in Patients of Septic Shock With Tachycardia

Status:
Not yet recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
A sigle-center, randomized controlled trial will be do to investigate the effects of esomol on heart rate, clinical parameters, mortality, and safety in septic shock patients with tachycardia at different stages, compared with patients who received conventional therapy.
Phase:
N/A
Details
Lead Sponsor:
Chinese Medical Association
Treatments:
Esmolol